Medical News

RSS

Study suggests effective way to counter influenza infections

McGill researchers, led by Dr. Maya Saleh of the Department of Medicine, have identified an enzyme, cIAP2 that helps the lungs protect themselves from the flu by giving them the ability to resist tissue damage. "It's a discovery that offers exciting new avenues for controlling influenza, since until now attempts to target the virus itself have proven challenging, especially in the face of emerging new strains of the virus," says Saleh, who is also a researcher at the Research Institute of the McGill University Health Centre.

15 Jan 2014

Coverage, payment confusion persists for insurers, consumers

The CT Mirror details how coverage delays are affecting consumers while the Sacramento Bee reports on how some insurers on California's health exchange have pushed back the due date for premium payments while others are not

15 Jan 2014

New study examines factors that may lead to end stage renal disease

About 33 percent of people with type 2 diabetes suffer kidney damage that progresses to end stage renal disease, at which point they require either dialysis or kidney transplantation. Scientists have thought that this kidney disease is driven by damage to the glomeruli, blood vessels in the kidney, which spill the protein albumin into the urine. Current treatments targeting the resulting "albuminuria" do not prevent kidney failure.

15 Jan 2014

International study develops refined method to identify individuals at risk for certain inherited cancer

An international study has developed a refined method to identify people at risk for certain inherited cancer as a result of Lynch syndrome.

15 Jan 2014

Spinal cord injury patients could benefit from careful assessment for sleep apnea

A new study suggests that patients with spinal cord injuries could benefit from careful assessment for sleep apnea.

15 Jan 2014

PGC-1α protein found in muscle may contributes to the development of type 2 diabetes later in life

A Montr-al research team led by Jennifer Estall at the IRCM discovered that a protein found in muscle tissue may contribute to the development of type 2 diabetes later in life. The study's results, published in today's printed edition of the scientific journal American Journal of Physiology - Endocrinology and Metabolism, indicate that the protein could be a promising early predictor of increased diabetes risk.

15 Jan 2014

Enrollment deadline extended for people in high-risk pools

A special insurance program for about 30,000 people with a history of cancer, heart disease and other serious illnesses will be extended for an additional two months so enrollees can continue treatments while they search for other coverage, the Obama administration announced Tuesday.

15 Jan 2014

Researchers explore new strategy to defeat drug-resistant strains of malaria

Malaria is one of the most deadly infectious diseases in the world today, claiming the lives of over half a million people every year, and the recent emergence of parasites resistant to current treatments threatens to undermine efforts to control the disease. Researchers are now onto a new strategy to defeat drug-resistant strains of the parasite. Their report appears in the journal ACS Chemical Biology.

15 Jan 2014

Researchers report three-fold increase in use of minimally invasive surgery for pancreatic disease

Researchers at University of California, San Diego School of Medicine report a three-fold increase in the use of minimally invasive surgery across the nation for patients with pancreatic disease. Although adaptation of MIS for this difficult-to-reach gland is recent, the growing trend points to improved patient outcomes, such as reduced bleeding and infections. Now published online, the paper will appear in the March print edition of JAMA Surgery.

15 Jan 2014

Varian Medical Systems' updated ProBeam proton therapy system gets FDA clearance

Varian Medical Systems has received FDA 510(k) clearance for its updated ProBeam proton therapy system.

15 Jan 2014

First commercial implant of Elixir's DESolve Novolimus Eluting Coronary Scaffold performed in Germany

Marking a milestone in the evolution of fully-bioresorbable drug-eluting scaffolds for interventional cardiology, the first commercial implant of Elixir Medical's CE Mark-approved DESolve Novolimus Eluting Coronary Scaffold was performed in Germany by Professor Dr. med. Holger Nef, Head of the Cardiac Catheterization Laboratory, University Hospital Giessen, Giessen, Germany.

15 Jan 2014

FDA accepts Iroko Pharmaceuticals' ZORVOLEX sNDA for review

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration has accepted for review the Supplemental New Drug Application for ZORVOLEX (diclofenac), a lower dose nonsteroidal anti-inflammatory drug, for the proposed indication of treatment of osteoarthritis pain in adults. ZORVOLEX was approved by FDA in October 2013 for the treatment of mild to moderate acute pain in adults.

15 Jan 2014

Call for long follow-up after CIN3 treatment

Researchers from Sweden say that women who have been treated for cervical precancer should receive lifelong follow-up, after finding that their risk for dying from vaginal or cervical cancer markedly increases after the age of 60 years.

15 Jan 2014

More evidence for glutamate dysregulation in schizophrenia

Levels of glutamine, but not glutamate, are elevated in the dorsal anterior cingulate of patients with established schizophrenia, say researchers.

15 Jan 2014

Emotion regulation deficits characterize bipolar and MDD patients

Patients with bipolar disorder and major depressive disorder have increased use of maladaptive and decreased use of adaptive emotion regulation strategies, researchers report.

15 Jan 2014

Research findings provide insights into risks associated with isolated mild hyperglycemia

Despite having mild hyperglycemia for approximately 50 years, patients with a mutation in the gene encoding the enzyme glucokinase had a low prevalence of clinically significant vascular complications, findings that provide insights into the risks associated with isolated mild hyperglycemia, according to a study in the January 15 issue of JAMA.

15 Jan 2014

First Edition: January 15, 2014

Today's headlines include reports about the announcement by the Department of Health and Human Services that people who get their health insurance through high-risk insurance pools will have an extra two months before this program ends.

15 Jan 2014

FAMPYRA now available in Ireland for symptomatic treatment of walking impairment in MS patients

Biogen Idec today announced that FAMPYRA (prolonged-release fampridine tablets) has been made available in Ireland for the symptomatic treatment of walking impairment in adults with Multiple Sclerosis. FAMPYRA is a prescription drug and is licensed for use in all types of the disease, including the progressive forms. FAMPYRA is available by way of retail pharmacy on a private payment basis.

15 Jan 2014

Coalfire launches HIPAAcentral service to help manage healthcare regulatory compliance data

Coalfire announced today the launch of HIPAAcentral, a new compliance exchange that provides a comprehensive suite of services for covered entities and business associates and their subcontractors to manage, maintain and exchange healthcare regulatory compliance data.

15 Jan 2014

State legislators contemplate flaws in New York's online insurance marketplace

Testimony during a New York State Senate hearing Monday explored problems that have emerged during the rollout of New York State of Health. News outlets also reported the latest related developments from Maryland and California.

15 Jan 2014

Medical News

Study suggests effective way to counter influenza infections

Coverage, payment confusion persists for insurers, consumers

New study examines factors that may lead to end stage renal disease

International study develops refined method to identify individuals at risk for certain inherited cancer

Spinal cord injury patients could benefit from careful assessment for sleep apnea

PGC-1α protein found in muscle may contributes to the development of type 2 diabetes later in life

Enrollment deadline extended for people in high-risk pools

Researchers explore new strategy to defeat drug-resistant strains of malaria

Researchers report three-fold increase in use of minimally invasive surgery for pancreatic disease

Varian Medical Systems' updated ProBeam proton therapy system gets FDA clearance

First commercial implant of Elixir's DESolve Novolimus Eluting Coronary Scaffold performed in Germany

FDA accepts Iroko Pharmaceuticals' ZORVOLEX sNDA for review

Call for long follow-up after CIN3 treatment

More evidence for glutamate dysregulation in schizophrenia

Emotion regulation deficits characterize bipolar and MDD patients

Research findings provide insights into risks associated with isolated mild hyperglycemia

First Edition: January 15, 2014

FAMPYRA now available in Ireland for symptomatic treatment of walking impairment in MS patients

Coalfire launches HIPAAcentral service to help manage healthcare regulatory compliance data

State legislators contemplate flaws in New York's online insurance marketplace

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News